US Expansion Momentum Sisu has established a U.S. presence with clinics in Merrick Park near Miami (2022) and a second New York City location (Flatiron, 2022), signaling ongoing expansion into the U.S. market. A $15 million venture debt facility secured in January 2025 indicates strong growth financing and capacity to scale operations, equipment, and marketing. This trajectory creates opportunities for U.S.-based suppliers, medical device manufacturers, clinic fit-out partners, and service providers looking to align with a growth-stage aesthetic leader.

Premium Doctor Led Sisu emphasizes a doctor-led, patient-centric approach designed to deliver superior results, positioning the brand as a premium option in a crowded market. This positioning opens doors for high-end skincare brands, exclusive product partnerships, co-branded campaigns, and professional training programs or certification partnerships targeting upscale clinics and medspas.

Product Line Growth In 2023 Sisu launched Sisu Solutions, a provider-approved skincare line, suggesting openness to wholesale distribution, private label opportunities, or bundle offerings with treatment services. This creates potential sales channels to clinics, spas, retailers, and e-commerce partners seeking clinically endorsed skincare aligned with cosmetic procedures.

Funding Signals Past financing activity shows a trajectory of growth: about 11 million raised in 2022, a 2.5 million debt financing in 2023, and a 15 million venture debt facility in 2025. This financial momentum supports equipment procurement, marketing expansion, and multi-location rollouts, making it feasible to offer financing-friendly deals, leasing programs, and co-investment partnerships with suppliers and distributors.

Talent and Training With a team of 51 to 200 professionals and a focus on clinical excellence, Sisu is likely to invest in staff training, recruitment, and quality assurance as it scales. This creates opportunities to provide clinical education programs, learning management systems, credentialing support, and recruitment partnerships to sustain rapid clinic expansion.